Science Corporation Closes $230 Million Series C to Accelerate Commercialization of Its PRIMA BCI Retinal Implant, the World’s Most Advanced Vision Restoration Technology
Syndicate Composed of Leading Investors Including Lightspeed Venture Partners, Khosla Ventures, Y Combinator, IQT, and Quiet Capital Company Expands PRIMA Clinical Trials to Include Additional Retinal Diseases ALAMEDA, Calif–(BUSINESS WIRE)–Science Corporation, the pioneering full-stack neural…